The Column Group Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
19
- Investments
-
103
- Portfolio
-
26
- Exits
-
25
The Column Group General Information
Description
Founded in 2007, The Column Group is a venture capital investment firm based in San Francisco, California. The firm prefers to invest in early-stage drug discovery companies based on their unique scientific platforms and the potential to deliver multiple breakthrough therapeutics.
Contact Information
Website
www.thecolumngroup.com
Year Founded
2007
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Primary Office
- 1 Letterman Drive Building D
- Suite DM-900
- San Francisco, CA 94129
- United States
+1 (415) 000-0000
The Column Group Investments (103)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Neurona Therapeutics | 22-Dec-2022 | Later Stage VC | 0000 | Drug Discovery | Clinical Trials - Phase 1 | 000000 00000 00.0 |
| 0000000000 | 06-Dec-2022 | 00000 00000 | 00000 | Drug Discovery | Generating Revenue | 0000000 0000000 00.0 |
| 00000 000000000000 | 29-Nov-2022 | 00000 00000 | 000.00 | Drug Discovery | Generating Revenue | |
| 0000000 0000000000 | 28-Nov-2022 | 00000 00000 | 00000 | Drug Discovery | Clinical Trials - Phase 2 | 000000 00000 00.0 |
| 0000000 000 | 30-Sep-2022 | 00000 00000 | 000.00 | Drug Discovery | Generating Revenue | 0000000 000 00.0 |
| 000000 00000000000 | 25-Jul-2022 | 00000 00000 | 00000 | Drug Discovery | Generating Revenue | 00000 0000000000 |
| 00000 000000000000 | 24-Mar-2022 | 00000 00000 | 0000 | Drug Discovery | Generating Revenue | 0000 0000 00.0 |
| 000000 000000 | 22-Mar-2022 | 00000 00000 | 000.00 | Drug Discovery | Generating Revenue | 00000 0000000000 |
| Plexium | 28-Feb-2022 | Later Stage VC | 00000 | Drug Discovery | Startup | 0000000 0000000 00.0 |
| InduPro (Biotechnology) | 18-Feb-2022 | Early Stage VC | 0000 | Biotechnology | Startup | 0000000 0000000 00.0 |
The Column Group Exits (25)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| eFFECTOR Therapeutics | 26-Aug-2021 | Reverse Merger | 00000 |
| 000000 00000000000 | 30-Jul-2021 | 000 | 00000 |
| 0000000000000 0000 | 15-Jul-2021 | 000000000000000000 | 00.000 |
| 00000 | 05-Mar-2021 | 000000 0000000000 | 00000 |
| 0000 0000000000000 | 13-Nov-2020 | 000000 0000000000 | 00000 |
| 00000 | 24-Jul-2020 | 000 | 00000 |
| 0000000000000 0000 | 17-Jun-2020 | 000000 0000000000 | 00000 |
| 0000 0000000000000 | 24-Apr-2020 | 000 | 00000 |
| Revolution Medicines | 13-Feb-2020 | IPO | 00000 |
| RAPT Therapeutics | 07-Feb-2020 | Public Investment 2nd Offering | 0000 |
The Column Group Fund Performance
| Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
|---|
The Column Group Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
The Column Group Team (34)
| Name | Title | Deals | Funds | Boards | Office |
|---|---|---|---|---|---|
| James Evangelista | Chief Financial Officer | 0 | San Francisco, CA | ||
| Peter Svennilson | Co-Founder & Managing Partner | 00 | 0 | 0 | San Francisco, CA |
| Peter Svennilson | Founder & Managing Partner | 0 | San Francisco, CA | ||
| David Goeddel Ph.D | Managing Partner | 00 | 0 | 0 | San Francisco, CA |
| Jeffrey Goater | Venture Partner | 0 | San Francisco, CA |
The Column Group Co-Investors (151)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Casdin Capital | 8 | 0 | 0 |
|
|
| Euclidean Capital | 0 | 0 |
|
|
|
| Foresite Capital Management | 0 | 0 | 0 |
|
|
| Nextech Invest | 0 | 0 | 0 |
|
|
| Lux Capital | 0 | 0 |
|
|